{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:21:09Z","timestamp":1790000469511,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.03.058","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T08:21:15Z","timestamp":1711527675000},"page":"2909-2918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel nucleotide-packaging vaccine delivers antigen and poly(I:C) to dendritic cells and generate a potent antibody response in vivo"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-8300","authenticated-orcid":false,"given":"Natasja","family":"Bruun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene F.","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5788-2542","authenticated-orcid":false,"given":"Rita","family":"Carmelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine S.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0540-1367","authenticated-orcid":false,"given":"Gunna","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-5606","authenticated-orcid":false,"given":"Svend","family":"Birkelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Agger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-8978","authenticated-orcid":false,"given":"Emil","family":"Kofod-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.03.058_b0005","unstructured":"World Health Organization. Immunization, 2019, https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/immunization [accessed 16 October 2023]."},{"key":"10.1016\/j.vaccine.2024.03.058_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pbiomolbio.2023.02.004","article-title":"An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines","volume":"178","author":"Bayani","year":"2023","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.vaccine.2024.03.058_b0015","doi-asserted-by":"crossref","unstructured":"Pulendran B, S. Arunachalam P, O\u2019Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Dis 2021;20(6):454-75.","DOI":"10.1038\/s41573-021-00163-y"},{"key":"10.1016\/j.vaccine.2024.03.058_b0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2012.00406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"Hogenesch","year":"2013","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.058_b0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.058_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020142","article-title":"TLR agonists as vaccine adjuvants targeting cancer and infectious diseases","volume":"13","author":"Luchner","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6857","key":"10.1016\/j.vaccine.2024.03.058_b0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-\u03baB by toll-like receptor 3","volume":"413","author":"Medzhitov","year":"2001","journal-title":"Nature (London)"},{"issue":"48","key":"10.1016\/j.vaccine.2024.03.058_b0040","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.vaccine.2014.06.065","article-title":"Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer","volume":"32","author":"Scheiermann","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.058_b0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-981-10-5987-2_9","article-title":"TLR agonists as adjuvants for cancer vaccines","volume":"1024","author":"Li","year":"2017","journal-title":"Regul Inflamm Signal Health Disease"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.058_b0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nchembio.1186","article-title":"Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells","volume":"9","author":"Barbuto","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.058_b0055","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2005.10.019","article-title":"DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells","volume":"13","author":"Fredriksen","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2024.03.058_b0060","doi-asserted-by":"crossref","unstructured":"Laursen MF, Christensen E, Degn LLT, J\u00f8nsson K, Jakobsen MR, Agger R, et al. CD11c-targeted Delivery of DNA to Dendritic Cells Leads to cGAS- and STING-dependent Maturation. Journal of immunotherapy (1997). 2018;41(1):9-18.","DOI":"10.1097\/CJI.0000000000000195"},{"issue":"6","key":"10.1016\/j.vaccine.2024.03.058_b0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/sji.12387","article-title":"Enhanced humoral responses induced by targeting of antigen to murine dendritic cells","volume":"82","author":"Pugholm","year":"2015","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.03.058_b0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/sji.12365","article-title":"In vitro assay for screening of optimal targets for antigen-delivery to murine dendritic cells","volume":"82","author":"Pugholm","year":"2015","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.058_b0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0928-8244(03)00300-6","article-title":"Identification of an in vivo CD4 + T cell-mediated response to polymorphic membrane proteins of chlamydia pneumoniae during experimental infection","volume":"40","author":"Mygind","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2024.03.058_b0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.resmic.2019.08.002","article-title":"The repeated 36 amino acid motif of chlamydia trachomatis Hc2 protein binds to the major groove of DNA","volume":"170","author":"Goncalves","year":"2019","journal-title":"Res Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.058_b0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/prep.1999.1162","article-title":"Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent","volume":"18","author":"Franken","year":"2000","journal-title":"Protein Expr Purif"},{"issue":"6","key":"10.1016\/j.vaccine.2024.03.058_b0095","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1128\/jb.175.6.1785-1795.1993","article-title":"Interaction between the chlamydia trachomatis histone H1-like protein (Hc1) and DNA","volume":"175","author":"Christiansen","year":"1993","journal-title":"Journal of Bacteriology: JB"},{"key":"10.1016\/j.vaccine.2024.03.058_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.bb.07.060178.000315","article-title":"Electron microscope visualization of chromatin and other DNA-protein complexes","volume":"7","author":"Griffith","year":"1978","journal-title":"Annu Rev Biophys Bioeng"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.058_b0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2958.1996.tb02618.x","article-title":"Purification of recombinant chlamydia trachomatis histone H1-like protein Hc2, and comparative functional analysis of Hc2 and Hc1","volume":"20","author":"Pedersen","year":"1996","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.058_b0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"7219","key":"10.1016\/j.vaccine.2024.03.058_b0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.058_b0135","first-page":"538","article-title":"The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation","volume":"29","author":"Zhong","year":"2008","journal-title":"Immunity (Cambridge, Mass)"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.058_b0140","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.1100469","article-title":"Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response","volume":"187","author":"Kis-Toth","year":"2011","journal-title":"J Immunol (1950)"},{"issue":"26","key":"10.1016\/j.vaccine.2024.03.058_b0145","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1182\/blood-2011-07-367615","article-title":"Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity","volume":"118","author":"Tacken","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.058_b0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00232-016-9940-z","article-title":"Progress in research and application of HIV-1 TAT-derived cell-penetrating peptide","volume":"250","author":"Zou","year":"2017","journal-title":"J Membr Biol"},{"issue":"47","key":"10.1016\/j.vaccine.2024.03.058_b0155","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1016\/j.vaccine.2011.09.052","article-title":"Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model","volume":"29","author":"Park","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.058_b0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0625.2009.00954.x","article-title":"Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide\/poly(I:C) complexes efficiently activate T cells","volume":"19","author":"Haenssle","year":"2010","journal-title":"Exp Dermatol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.03.058_b0165","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2024.03.058_b0170","doi-asserted-by":"crossref","unstructured":"Cornell JCJ, Smith KA, Cornwell rGG, Burke GP, McIntyre OR. Ssytemic effects of intravenous polyriboinosinic-polyribocytidylic acid in man. JNCI : Journal of the National Cancer Institute. 1976;57(6):1211-6.","DOI":"10.1093\/jnci\/57.6.1211"},{"issue":"5","key":"10.1016\/j.vaccine.2024.03.058_b0175","first-page":"889","article-title":"The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors","volume":"32","author":"Fisher","year":"1972","journal-title":"Cancer research (Chicago, Ill)"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.058_b0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0041-008X(72)90098-1","article-title":"Studies on poly I: C toxicity in experimental animals","volume":"23","author":"Homan","year":"1972","journal-title":"Toxicol Appl Pharmacol"},{"issue":"21","key":"10.1016\/j.vaccine.2024.03.058_b0185","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.01410-12","article-title":"Intranasal treatment with Poly(I\u00b7C) protects aged mice from lethal respiratory virus infections","volume":"86","author":"Zhao","year":"2012","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2024.03.058_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112918","article-title":"Poly(I:C) induces antiviral immune responses in japanese flounder (Paralichthys olivaceus) that require TLR3 and MDA5 and is negatively regulated by Myd88","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.058_b0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41419-020-03283-2","article-title":"Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections","volume":"12","author":"Gao","year":"2021","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2024.03.058_b0200","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.0711976105","article-title":"The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine","volume":"105","author":"Trumpfheller","year":"2008","journal-title":"Proc Nat Acad Sci - PNAS"},{"key":"10.1016\/j.vaccine.2024.03.058_b0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3389\/fimmu.2019.00843","article-title":"Poly(I:C) potentiates T cell immunity to a dendritic cell targeted HIV-multiepitope vaccine","volume":"10","author":"Apost\u00f3lico","year":"2019","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T05:35:26Z","timestamp":1712986526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24003645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24003645"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel nucleotide-packaging vaccine delivers antigen and poly(I:C) to dendritic cells and generate a potent antibody response in vivo","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}